25 XP   0   0   10

Atossa Genetics Inc
Buy, Hold or Sell?

Let's analyse Atossa Genetics Inc together

PenkeI guess you are interested in Atossa Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atossa Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Atossa Genetics Inc

I send you an email if I find something interesting about Atossa Genetics Inc.

Quick analysis of Atossa Genetics Inc (30 sec.)










What can you expect buying and holding a share of Atossa Genetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.78
Expected worth in 1 year
$0.58
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.20
Return On Investment
-15.3%

For what price can you sell your share?

Current Price per Share
$1.29
Expected price per share
$1.05 - $1.39
How sure are you?
50%

1. Valuation of Atossa Genetics Inc (5 min.)




Live pricePrice per Share (EOD)

$1.29

Intrinsic Value Per Share

$-1.56 - $-0.95

Total Value Per Share

$-0.77 - $-0.17

2. Growth of Atossa Genetics Inc (5 min.)




Is Atossa Genetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$98.2m$131.8m-$23.2m-21.4%

How much money is Atossa Genetics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$6m-$1m-14.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Atossa Genetics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#391 / 1037

Most Revenue
#876 / 1037

Most Profit
#524 / 1037

Most Efficient
#328 / 1037

What can you expect buying and holding a share of Atossa Genetics Inc? (5 min.)

Welcome investor! Atossa Genetics Inc's management wants to use your money to grow the business. In return you get a share of Atossa Genetics Inc.

What can you expect buying and holding a share of Atossa Genetics Inc?

First you should know what it really means to hold a share of Atossa Genetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Atossa Genetics Inc is $1.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atossa Genetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atossa Genetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.78. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atossa Genetics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-3.8%-0.06-4.6%-0.05-3.7%-0.04-3.4%-0.04-2.8%
Usd Book Value Change Per Share-0.05-3.7%-0.05-3.8%-0.03-2.7%0.032.7%0.021.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.3%0.000.1%
Usd Total Gains Per Share-0.05-3.7%-0.05-3.8%-0.03-2.7%0.043.0%0.021.5%
Usd Price Per Share0.74-0.81-1.19-1.94-1.55-
Price to Earnings Ratio-3.72--3.42--6.80--13.36--3.80-
Price-to-Total Gains Ratio-15.60--16.37--39.80--29.67-6.72-
Price to Book Ratio0.94-0.96-1.14-10.63-16.11-
Price-to-Total Gains Ratio-15.60--16.37--39.80--29.67-6.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.29
Number of shares775
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.03
Usd Total Gains Per Share-0.050.04
Gains per Quarter (775 shares)-38.1929.78
Gains per Year (775 shares)-152.74119.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-153-16311108109
20-305-31622216228
30-458-46933324347
40-611-62245432466
50-764-77556540585
60-916-92867648704
70-1069-108178756823
80-1222-123489864942
90-1375-13871009721061
100-1527-154011110801180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.052.00.01.9%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%13.027.00.032.5%19.032.02.035.8%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%3.00.050.05.7%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%13.027.00.032.5%19.032.02.035.8%

Fundamentals of Atossa Genetics Inc

About Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need in oncology. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201 for lung injury caused by cancer treatment. In addition, the company develops immunotherapy/chimeric antigen receptor therapy programs. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-02-27 17:53:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Atossa Genetics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Atossa Genetics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-3,618.9%+3,618.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--172.8%+172.8%
TTM--206.5%+206.5%
YOY--251.7%+251.7%
5Y--465.8%+465.8%
10Y-3,618.9%-595.4%-3,023.5%
1.1.2. Return on Assets

Shows how efficient Atossa Genetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -6.1% Return on Assets means that Atossa Genetics Inc generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atossa Genetics Inc:

  • The MRQ is -6.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.1%TTM-6.4%+0.2%
TTM-6.4%YOY-4.5%-1.8%
TTM-6.4%5Y-14.0%+7.6%
5Y-14.0%10Y-24.9%+10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.1%-12.4%+6.3%
TTM-6.4%-12.2%+5.8%
YOY-4.5%-11.1%+6.6%
5Y-14.0%-13.6%-0.4%
10Y-24.9%-15.1%-9.8%
1.1.3. Return on Equity

Shows how efficient Atossa Genetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -6.3% Return on Equity means Atossa Genetics Inc generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atossa Genetics Inc:

  • The MRQ is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-6.6%+0.2%
TTM-6.6%YOY-4.6%-1.9%
TTM-6.6%5Y-16.0%+9.4%
5Y-16.0%10Y-32.7%+16.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-15.8%+9.5%
TTM-6.6%-15.8%+9.2%
YOY-4.6%-14.1%+9.5%
5Y-16.0%-18.3%+2.3%
10Y-32.7%-19.4%-13.3%

1.2. Operating Efficiency of Atossa Genetics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Atossa Genetics Inc is operating .

  • Measures how much profit Atossa Genetics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-3,620.2%+3,620.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--314.9%+314.9%
TTM--211.1%+211.1%
YOY--276.2%+276.2%
5Y--459.9%+459.9%
10Y-3,620.2%-596.5%-3,023.7%
1.2.2. Operating Ratio

Measures how efficient Atossa Genetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y67.028-67.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.876-2.876
TTM-3.223-3.223
YOY-3.547-3.547
5Y-5.795-5.795
10Y67.0287.396+59.632

1.3. Liquidity of Atossa Genetics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 28.35 means the company has $28.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Atossa Genetics Inc:

  • The MRQ is 28.353. The company is very able to pay all its short-term debts. +2
  • The TTM is 29.430. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ28.353TTM29.430-1.077
TTM29.430YOY45.582-16.152
TTM29.4305Y32.707-3.278
5Y32.70710Y18.799+13.909
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.3533.992+24.361
TTM29.4304.478+24.952
YOY45.5825.562+40.020
5Y32.7076.255+26.452
10Y18.7996.509+12.290
1.3.2. Quick Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 27.31 means the company can pay off $27.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atossa Genetics Inc:

  • The MRQ is 27.311. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 27.920. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ27.311TTM27.920-0.609
TTM27.920YOY43.841-15.920
TTM27.9205Y31.480-3.560
5Y31.48010Y18.082+13.398
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.3113.662+23.649
TTM27.9204.184+23.736
YOY43.8415.484+38.357
5Y31.4806.041+25.439
10Y18.0826.333+11.749

1.4. Solvency of Atossa Genetics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Atossa Genetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atossa Genetics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that Atossa Genetics Inc assets are financed with 3.4% credit (debt) and the remaining percentage (100% - 3.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.034. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.034. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.034TTM0.0340.000
TTM0.034YOY0.022+0.012
TTM0.0345Y0.079-0.045
5Y0.07910Y0.148-0.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0340.331-0.297
TTM0.0340.325-0.291
YOY0.0220.264-0.242
5Y0.0790.371-0.292
10Y0.1480.380-0.232
1.4.2. Debt to Equity Ratio

Measures if Atossa Genetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 3.5% means that company has $0.04 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.035. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.035. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.035TTM0.0350.000
TTM0.035YOY0.023+0.012
TTM0.0355Y0.099-0.064
5Y0.09910Y0.198-0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0350.371-0.336
TTM0.0350.396-0.361
YOY0.0230.332-0.309
5Y0.0990.428-0.329
10Y0.1980.479-0.281

2. Market Valuation of Atossa Genetics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Atossa Genetics Inc generates.

  • Above 15 is considered overpriced but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.72 means the investor is paying $-3.72 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atossa Genetics Inc:

  • The EOD is -6.513. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.718. Based on the earnings, the company is expensive. -2
  • The TTM is -3.416. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.513MRQ-3.718-2.794
MRQ-3.718TTM-3.416-0.303
TTM-3.416YOY-6.802+3.386
TTM-3.4165Y-13.362+9.947
5Y-13.36210Y-3.795-9.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.513-2.699-3.814
MRQ-3.718-2.251-1.467
TTM-3.416-2.823-0.593
YOY-6.802-4.293-2.509
5Y-13.362-6.216-7.146
10Y-3.795-6.249+2.454
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atossa Genetics Inc:

  • The EOD is -10.445. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.963. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.458. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.445MRQ-5.963-4.482
MRQ-5.963TTM-5.458-0.506
TTM-5.458YOY-8.143+2.685
TTM-5.4585Y-19.610+14.153
5Y-19.61010Y-14.313-5.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.445-3.506-6.939
MRQ-5.963-2.833-3.130
TTM-5.458-3.461-1.997
YOY-8.143-5.896-2.247
5Y-19.610-8.460-11.150
10Y-14.313-8.868-5.445
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Atossa Genetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.94 means the investor is paying $0.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Atossa Genetics Inc:

  • The EOD is 1.652. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.943. Based on the equity, the company is cheap. +2
  • The TTM is 0.960. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.652MRQ0.943+0.709
MRQ0.943TTM0.960-0.018
TTM0.960YOY1.137-0.177
TTM0.9605Y10.630-9.670
5Y10.63010Y16.105-5.475
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6522.111-0.459
MRQ0.9431.879-0.936
TTM0.9602.119-1.159
YOY1.1372.970-1.833
5Y10.6303.686+6.944
10Y16.1054.058+12.047
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Atossa Genetics Inc.

3.1. Institutions holding Atossa Genetics Inc

Institutions are holding 13.063% of the shares of Atossa Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc4.52960.0001567572400
2023-09-30BlackRock Inc2.30360.00012886517-11949-0.4123
2023-09-30LAURION CAPITAL MANAGEMENT LP1.77630.01222580000
2023-12-31Renaissance Technologies Corp1.02490.00181284270419003.3726
2023-09-30Geode Capital Management, LLC0.87990.00011102576-10036-0.902
2023-12-31GSA Capital Partners LLP0.35840.033244908210169029.2724
2023-09-30State Street Corporation0.3482043627100
2023-09-30Susquehanna International Group, LLP0.19830248504-124528-33.3827
2023-09-30Millennium Management LLC0.19130.0001239704-76701-24.2414
2023-09-30Northern Trust Corp0.1713021464200
2023-12-31Two Sigma Investments LLC0.12870.0003161320-12616-7.2532
2023-09-30Morgan Stanley - Brokerage Accounts0.11950149757-46134-23.5509
2023-09-30Group One Trading, LP0.10430.00031307355610075.1658
2023-12-31Connor Clark & Lunn Inv Mgmt Ltd0.0960.0005120328-13263-9.9281
2023-09-30Bank of New York Mellon Corp0.08850110848-1808-1.6049
2023-09-30Mariner Wealth Advisors, LLC0.08450.000210591010000.9532
2023-12-31XTX Topco Ltd0.06810.016585369-82058-49.0112
2023-09-30Virtu Financial LLC0.06440.005980728-6085-7.0093
2023-09-30Edmond de Rothschild Holding S.A.0.03990.00075000000
2023-09-30LPL Financial Corp0.039904999230006.3841
Total 12.61560.069815808077-181488-1.1%

3.2. Funds holding Atossa Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv3.01620.0002377937600
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.32820.0015166434500
2023-12-31Fidelity Extended Market Index0.49450.0015619595-1556-0.2505
2023-09-30BlackRock Extended Mkt Composite0.2230.001527946900
2023-06-30Rural Perfil Conservador FI0.19950.1084250023-149140-37.3632
2024-01-31BlackRock Advantage Small Cap Core Instl0.19810.005924822800
2023-12-31BlackRock Extended Equity Market K0.19460.0016243813-491-0.201
2023-12-31Fidelity Total Market Index0.1460.000218291100
2023-12-31Fidelity Series Total Market Index0.11350.000214216700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08780.001511003500
2023-12-31Northern Trust Extended Eq Market Idx0.08560.00161072231328014.1362
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08560.00161072231328014.1362
2024-01-31Vanguard Balanced Index Inv0.07830.00029809600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07050.0016883741660.1882
2024-01-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06990.00028755800
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06990.000287558-3691818-97.6833
2023-12-31Fidelity Nasdaq Composite Index0.06230.00057803500
2023-12-31Spartan Total Market Index Pool E0.04590.00025750000
2023-12-31BlackRock U.S. Equity Market F0.04190.000352524940.1793
2024-01-31Vanguard U.S. Eq Idx £ Acc0.0370.00024634900
Total 6.64830.12918330402-3816185-45.8%

3.3. Insider Transactions

Insiders are holding 0.042% of the shares of Atossa Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-07-02Gregory L WeaverSELL1074975.58

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Atossa Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.047-0.049+4%-0.035-26%0.035-236%0.017-374%
Book Value Per Share--0.7810.859-9%1.041-25%0.601+30%0.334+134%
Current Ratio--28.35329.430-4%45.582-38%32.707-13%18.799+51%
Debt To Asset Ratio--0.0340.034-1%0.022+51%0.079-57%0.148-77%
Debt To Equity Ratio--0.0350.035-1%0.023+52%0.099-65%0.198-82%
Dividend Per Share----0%-0%0.004-100%0.002-100%
Eps---0.050-0.059+19%-0.048-3%-0.044-11%-0.036-27%
Free Cash Flow Per Share---0.031-0.039+28%-0.039+27%-0.030-3%-0.024-21%
Free Cash Flow To Equity Per Share---0.043-0.016-63%-0.002-95%0.052-182%0.030-243%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.035-3%
Intrinsic Value_10Y_max---0.948--------
Intrinsic Value_10Y_min---1.556--------
Intrinsic Value_1Y_max---0.097--------
Intrinsic Value_1Y_min---0.150--------
Intrinsic Value_3Y_max---0.290--------
Intrinsic Value_3Y_min---0.459--------
Intrinsic Value_5Y_max---0.481--------
Intrinsic Value_5Y_min---0.774--------
Market Cap161642160.000+43%92646544.500102725511.525-10%151069002.400-39%243990856.785-62%194274847.973-52%
Net Profit Margin----0%-0%-0%-36.1890%
Operating Margin----0%-0%-0%-36.2020%
Operating Ratio----0%-0%-0%67.028-100%
Pb Ratio1.652+43%0.9430.960-2%1.137-17%10.630-91%16.105-94%
Pe Ratio-6.513-75%-3.718-3.416-8%-6.802+83%-13.362+259%-3.795+2%
Price Per Share1.290+43%0.7370.812-9%1.193-38%1.942-62%1.548-52%
Price To Free Cash Flow Ratio-10.445-75%-5.963-5.458-8%-8.143+37%-19.610+229%-14.313+140%
Price To Total Gains Ratio-27.325-75%-15.601-16.375+5%-39.796+155%-29.671+90%6.721-332%
Quick Ratio--27.31127.920-2%43.841-38%31.480-13%18.082+51%
Return On Assets---0.061-0.064+4%-0.045-26%-0.140+128%-0.249+307%
Return On Equity---0.063-0.066+4%-0.046-27%-0.160+153%-0.327+416%
Total Gains Per Share---0.047-0.049+4%-0.035-26%0.038-223%0.019-348%
Usd Book Value--98251000.000108587000.000-10%131851000.000-25%75860531.800+30%42155835.525+133%
Usd Book Value Change Per Share---0.047-0.049+4%-0.035-26%0.035-236%0.017-374%
Usd Book Value Per Share--0.7810.859-9%1.041-25%0.601+30%0.334+134%
Usd Dividend Per Share----0%-0%0.004-100%0.002-100%
Usd Eps---0.050-0.059+19%-0.048-3%-0.044-11%-0.036-27%
Usd Free Cash Flow---3884000.000-4978750.000+28%-4980250.500+28%-3792540.900-2%-3053021.650-21%
Usd Free Cash Flow Per Share---0.031-0.039+28%-0.039+27%-0.030-3%-0.024-21%
Usd Free Cash Flow To Equity Per Share---0.043-0.016-63%-0.002-95%0.052-182%0.030-243%
Usd Market Cap161642160.000+43%92646544.500102725511.525-10%151069002.400-39%243990856.785-62%194274847.973-52%
Usd Price Per Share1.290+43%0.7370.812-9%1.193-38%1.942-62%1.548-52%
Usd Profit---6229000.000-7091000.000+14%-6055634.500-3%-5275341.900-15%-4062527.550-35%
Usd Revenue----0%-0%-0%-119074.6500%
Usd Total Gains Per Share---0.047-0.049+4%-0.035-26%0.038-223%0.019-348%
 EOD+5 -3MRQTTM+19 -10YOY+6 -235Y+10 -2110Y+12 -21

4.2. Fundamental Score

Let's check the fundamental score of Atossa Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.513
Price to Book Ratio (EOD)Between0-11.652
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than127.311
Current Ratio (MRQ)Greater than128.353
Debt to Asset Ratio (MRQ)Less than10.034
Debt to Equity Ratio (MRQ)Less than10.035
Return on Equity (MRQ)Greater than0.15-0.063
Return on Assets (MRQ)Greater than0.05-0.061
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Atossa Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.235
Ma 20Greater thanMa 501.097
Ma 50Greater thanMa 1000.974
Ma 100Greater thanMa 2000.857
OpenGreater thanClose1.290
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Other Stockholders Equity  249,2391,545250,7841,573252,3572,033254,390-255,865-1,475



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets101,695
Total Liabilities3,444
Total Stockholder Equity98,251
 As reported
Total Liabilities 3,444
Total Stockholder Equity+ 98,251
Total Assets = 101,695

Assets

Total Assets101,695
Total Current Assets97,648
Long-term Assets4,047
Total Current Assets
Cash And Cash Equivalents 94,031
Net Receivables 28
Inventory 3,582
Other Current Assets 7
Total Current Assets  (as reported)97,648
Total Current Assets  (calculated)97,648
+/-0
Long-term Assets
Long Term Investments 1,710
Long-term Assets Other 2,337
Long-term Assets  (as reported)4,047
Long-term Assets  (calculated)4,047
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,444
Long-term Liabilities0
Total Stockholder Equity98,251
Total Current Liabilities
Accounts payable 718
Other Current Liabilities 2,726
Total Current Liabilities  (as reported)3,444
Total Current Liabilities  (calculated)3,444
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock22,792
Retained Earnings -178,534
Accumulated Other Comprehensive Income 254,886
Other Stockholders Equity -1,475
Total Stockholder Equity (as reported)98,251
Total Stockholder Equity (calculated)97,669
+/- 582
Other
Capital Stock22,792
Cash and Short Term Investments 94,031
Common Stock Shares Outstanding 125,793
Liabilities and Stockholders Equity 101,695
Net Debt -94,031
Net Invested Capital 98,251
Net Working Capital 94,204



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302009-12-312009-09-30
> Total Assets 
0
85
41
32
15
0
0
4,135
3,072
1,366
843
5,692
6,826
8,912
10,055
13,482
12,009
22,383
19,819
16,772
11,764
13,803
16,561
12,357
6,243
5,100
3,285
6,278
4,144
2,303
4,709
3,635
8,164
5,980
16,578
14,124
11,720
21,025
18,609
16,597
14,490
11,812
10,206
11,438
42,839
141,081
145,868
143,024
141,262
137,478
134,048
126,724
123,532
116,200
108,355
101,695
101,695108,355116,200123,532126,724134,048137,478141,262143,024145,868141,08142,83911,43810,20611,81214,49016,59718,60921,02511,72014,12416,5785,9808,1643,6354,7092,3034,1446,2783,2855,1006,24312,35716,56113,80311,76416,77219,81922,38312,00913,48210,0558,9126,8265,6928431,3663,0724,13500153241850
   > Total Current Assets 
0
0
40
31
10
0
0
4,050
2,945
1,215
701
885
1,989
4,166
5,355
8,595
7,414
17,700
14,674
11,716
9,086
11,367
13,756
9,542
4,295
3,386
1,455
4,564
3,255
1,517
3,976
2,950
7,898
5,735
16,408
13,923
11,549
20,780
18,388
16,401
14,319
11,667
10,062
11,318
42,770
141,031
145,831
142,987
141,240
136,848
133,421
123,395
118,197
110,869
106,003
97,648
97,648106,003110,869118,197123,395133,421136,848141,240142,987145,831141,03142,77011,31810,06211,66714,31916,40118,38820,78011,54913,92316,4085,7357,8982,9503,9761,5173,2554,5641,4553,3864,2959,54213,75611,3679,08611,71614,67417,7007,4148,5955,3554,1661,9898857011,2152,9454,0500010314000
       Cash And Cash Equivalents 
0
84
32
30
10
0
0
3,006
1,911
899
90
419
1,725
1,385
2,487
7,737
6,342
16,591
14,298
11,374
8,501
9,728
11,403
7,839
3,716
2,883
1,191
4,388
3,028
1,167
3,690
2,734
7,217
4,780
15,237
12,936
10,380
19,568
17,059
15,290
12,581
9,351
7,463
9,106
39,554
137,574
142,433
140,041
136,377
131,486
125,537
117,367
110,890
103,868
99,390
94,031
94,03199,390103,868110,890117,367125,537131,486136,377140,041142,433137,57439,5549,1067,4639,35112,58115,29017,05919,56810,38012,93615,2374,7807,2172,7343,6901,1673,0284,3881,1912,8833,7167,83911,4039,7288,50111,37414,29816,5916,3427,7372,4871,3851,725419908991,9113,00600103032840
       Short-term Investments 
0
0
0
0
0
0
0
0
1,000
0
251
250
0
0
0
0
0
0
0
0
0
0
0
275
275
275
55
55
55
55
55
55
55
55
55
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000555555555555555555552752752750000000000025025101,00000000000
       Net Receivables 
0
0
0
0
0
0
0
0
1
46
179
175
142
259
520
299
139
91
48
29
298
1,280
2,012
1,055
76
76
268
228
194
149
3
4
358
396
626
480
518
238
406
569
740
734
761
439
635
720
817
935
1,072
668
900
610
743
738
737
28
287377387436109006681,0729358177206354397617347405694062385184806263963584314919422826876761,0552,0121,28029829489113929952025914217517946100000000
       Other Current Assets 
0
0
8
2
0
0
0
2
2
2
431
2
123
2,521
2,348
559
933
1,018
325
267
247
264
239
477
111
503
264
176
14
350
283
212
16
9
50
162
31
28
0
2
26
135
264
179
658
77
79
18
1,193
710
1,570
201
2,423
858
7
7
778582,4232011,5707101,1931879776581792641352620283116250916212283350141762645031114772392642472673251,0189335592,3482,52112324312220002800
   > Long-term Assets 
0
0
1
1
5
0
0
85
126
151
142
4,807
4,837
4,746
4,700
4,887
4,595
4,683
5,145
5,056
2,678
2,436
2,806
2,815
1,948
1,714
1,830
1,714
890
786
733
685
266
245
170
201
171
245
221
196
170
145
144
119
69
49
37
37
22
630
627
3,329
5,335
5,331
2,352
4,047
4,0472,3525,3315,3353,32962763022373749691191441451701962212451712011702452666857337868901,7141,8301,7141,9482,8152,8062,4362,6785,0565,1454,6834,5954,8874,7004,7464,8374,807142151126850051100
       Property Plant Equipment 
0
0
0
0
0
0
0
34
80
76
72
67
160
150
206
443
163
130
128
185
358
382
360
485
172
146
114
85
55
28
19
14
11
60
61
58
54
136
120
102
84
67
74
57
39
24
19
23
20
0
0
0
0
0
0
0
00000002023192439577467841021201365458616011141928558511414617248536038235818512813016344320615016067727680340000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,700
4,700
4,700
1,710
1,710
1,7101,7104,7004,7002,700000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
45
41
37
32
4,703
4,640
4,559
4,458
4,407
4,396
4,492
4,454
4,365
1,921
1,878
1,822
1,769
1,701
1,492
1,447
1,402
640
610
586
561
76
71
60
55
99
92
84
76
69
61
53
45
13
9
4
0
0
0
0
0
0
0
0
0
00000000049134553616976849299556071765615866106401,4021,4471,4921,7011,7691,8221,8781,9214,3654,4544,4924,3964,4074,4584,5594,6404,703323741450000000
       Other Assets 
0
1
0
0
5
0
0
0
46
0
70
4,740
4,677
4,596
4,494
4,444
4,432
4,553
5,017
4,871
2,320
2,054
2,445
2,330
1,776
1,568
1,715
1,629
834
758
714
671
255
115
49
89
17
17
17
17
0
17
17
74
56
16
13
13
2
630
627
3,329
635
0
0
0
0006353,32962763021313165674171701717171789491152556717147588341,6291,7151,5681,7762,3302,4452,0542,3204,8715,0174,5534,4324,4444,4944,5964,6774,7407004600050010
> Total Liabilities 
0
0
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,266
3,519
3,436
3,298
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,529
1,057
1,578
1,334
916
1,831
1,567
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
3,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5671,8319161,3341,5781,0571,5292,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2983,4363,5192,2661,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,399008675599800
   > Total Current Liabilities 
0
54
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,214
3,487
3,414
3,293
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,491
1,033
1,564
1,323
908
1,827
1,565
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
3,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5651,8279081,3231,5641,0331,4912,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2933,4143,4872,2141,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,3990086755998540
       Short-term Debt 
0
0
5
107
189
0
0
1,010
1,005
250
250
330
0
0
1,486
1,427
1,114
0
0
0
76
80
72
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
52
49
39
29
40
30
18
8
5
1
0
0
0
0
0
0
0
0
000000001581830402939495251000000000000007280760001,1141,4271,486003302502501,0051,01000189107500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000510000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
65
97
71
72
68
35
184
31
10
196
790
439
594
966
581
1,179
814
429
283
197
254
387
496
380
335
168
191
551
353
464
318
501
293
356
1,033
683
1,589
722
538
668
1,717
1,596
2,052
1,653
2,965
1,444
1,174
718
7181,1741,4442,9651,6532,0521,5961,7176685387221,5896831,0333562935013184643535511911683353804963872541972834298141,179581966594439790196103118435687271976500000000
       Other Current Liabilities 
0
49
93
452
678
0
0
389
442
433
1,077
1,969
1,582
1,902
32
423
235
1,047
773
1,100
42
43
20
2,113
1,687
898
591
666
793
388
1,410
691
891
552
2,820
3,005
2,562
10
20
18
13
3
6
15
13,008
8
21
18
1,409
726
1,740
1,215
2,603
1,500
2,304
2,726
2,7262,3041,5002,6031,2151,7407261,4091821813,0081563131820102,5623,0052,8205528916911,4103887936665918981,6872,1132043421,1007731,047235423321,9021,5821,9691,0774334423890067845293490
   > Long-term Liabilities 
0
0
5
107
189
0
0
1,010
1,070
347
321
322
68
35
257
92
58
35
790
439
52
32
23
6
814
429
283
197
254
387
496
380
335
168
191
551
353
37
24
14
11
8
5
1
1,607
730
543
669
1,717
1,596
2,052
1,653
2,965
1,444
0
0
001,4442,9651,6532,0521,5961,7176695437301,60715811142437353551191168335380496387254197283429814623325243979035589225735683223213471,0701,01000189107500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
25
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000013254900000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000005107200000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000006107200000000000000000000
> Total Stockholder Equity
0
0
-57
-527
-852
0
0
2,736
1,560
587
-555
3,402
5,176
6,976
8,281
11,540
10,602
21,301
18,256
15,233
9,498
10,284
13,125
9,059
3,742
3,773
2,410
5,414
3,097
1,528
2,804
2,563
6,939
5,260
13,567
10,569
8,805
19,496
17,552
15,018
13,156
10,896
8,374
9,871
27,168
139,701
144,072
141,348
138,136
135,156
130,256
123,856
117,964
113,256
104,877
98,251
98,251104,877113,256117,964123,856130,256135,156138,136141,348144,072139,70127,1689,8718,37410,89613,15615,01817,55219,4968,80510,56913,5675,2606,9392,5632,8041,5283,0975,4142,4103,7733,7429,05913,12510,2849,49815,23318,25621,30110,60211,5408,2816,9765,1763,402-5555871,5602,73600-852-527-5700
   Common Stock
0
5
6
6
6
0
0
11
11
11
11
12
13
15
15
17
19
24
24
25
25
27
29
30
33
39
40
57
57
57
150
210
477
477
877
994
1,052
1,642
1,643
1,644
1,644
1,644
1,675
1,884
8,559
21,748
22,667
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,79222,79222,79222,79222,79222,79222,79222,79222,79222,66721,7488,5591,8841,6751,6441,6441,6441,6431,6421,05299487747747721015057575740393330292725252424191715151312111111110066650
   Retained Earnings Total Equity0-172,305-162,475-156,194-148,703-140,691-134,020-129,234-124,402-119,205-112,166-111,899-104,416-100,925-97,018-94,071-91,453-88,167-80,905-76,831-74,753-71,443-67,301-65,426-63,433-61,249-59,007-57,304-54,780-54,985-53,262-50,935-45,973-41,655-38,510-35,175-29,362-26,116-22,928-20,517-17,759-14,257-11,673-9,732-8,02600000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-1
0
-10
-15
-19
-31
-41
-67
-94
-272
-294
-313
-338
-259
-290
-322
-356
-114
-144
-176
-206
-155
-143
-152
-156
-159
-159
0
0
0
0
0
0
-151
-151
0
0
0
0
0
0
0
-582
0
-54
-582
0
-582
254,886
254,886-5820-582-540-5820000000-151-151000000-159-159-156-152-143-155-206-176-144-114-356-322-290-259-338-313-294-272-94-67-41-31-19-15-100-10000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
11,416
14,895
18,634
22,523
29,281
31,100
44,205
44,347
44,570
44,648
48,766
54,751
55,002
54,644
56,997
57,356
60,138
60,344
60,479
63,872
65,786
71,888
72,083
78,331
84,328
84,584
98,759
104,076
104,828
105,583
106,271
107,624
112,403
130,508
230,119
240,610
242,958
244,578
246,384
248,155
249,821
251,366
252,939
254,542
0
0254,542252,939251,366249,821248,155246,384244,578242,958240,610230,119130,508112,403107,624106,271105,583104,828104,07698,75984,58484,32878,33172,08371,88865,78663,87260,47960,34460,13857,35656,99754,64455,00254,75148,76644,64844,57044,34744,20531,10029,28122,52318,63414,89511,41600000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
322
335
352
0
0
6,173
6,201
6,301
6,331
11,435
14,926
18,675
22,589
29,375
31,372
44,498
44,661
44,908
44,907
49,056
55,073
55,358
54,758
57,141
57,532
60,344
60,499
60,622
64,054
65,942
72,047
72,083
84,133
84,328
84,584
98,759
104,076
104,828
105,734
106,271
107,624
112,403
130,508
230,119
240,610
242,958
244,578
246,384
247,573
249,239
250,784
252,357
254,390
-1,475
-1,475254,390252,357250,784249,239247,573246,384244,578242,958240,610230,119130,508112,403107,624106,271105,734104,828104,07698,75984,58484,32884,13372,08372,04765,94264,05460,62260,49960,34457,53257,14154,75855,35855,07349,05644,90744,90844,66144,49831,37229,37522,58918,67514,92611,4356,3316,3016,2016,1730035233532200



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-30,496
Operating Income-30,496-30,496
 
Operating Expense (+$)
Research Development16,666
Selling General Administrative13,830
Selling And Marketing Expenses-
Operating Expense30,49630,496
 
Net Interest Income (+$)
Interest Income3,777
Interest Expense--
Other Finance Cost-0
Net Interest Income3,777
 
Pretax Income (+$)
Operating Income-30,496
Net Interest Income3,777
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-29,831-27,384
EBIT - interestExpense = 0
-29,831
-29,831
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--29,831
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-29,831
Tax Provision-0
Net Income From Continuing Ops-29,831-29,831
Net Income-29,831
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-3,112-3,777
 

Technical Analysis of Atossa Genetics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atossa Genetics Inc. The general trend of Atossa Genetics Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atossa Genetics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atossa Genetics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.38 < 1.38 < 1.39.

The bearish price targets are: 1.1 > 1.05 > 1.05.

Tweet this
Atossa Genetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atossa Genetics Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atossa Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atossa Genetics Inc. The current macd is 0.08917513.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Atossa Genetics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Atossa Genetics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Atossa Genetics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Atossa Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAtossa Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atossa Genetics Inc. The current adx is 38.09.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Atossa Genetics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Atossa Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atossa Genetics Inc. The current sar is 1.1.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Atossa Genetics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atossa Genetics Inc. The current rsi is 68.23. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Atossa Genetics Inc Daily Relative Strength Index (RSI) ChartAtossa Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atossa Genetics Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Atossa Genetics Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Atossa Genetics Inc Daily Stochastic Oscillator ChartAtossa Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atossa Genetics Inc. The current cci is 135.16.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Atossa Genetics Inc Daily Commodity Channel Index (CCI) ChartAtossa Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atossa Genetics Inc. The current cmo is 37.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Atossa Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartAtossa Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atossa Genetics Inc. The current willr is -13.34581439.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Atossa Genetics Inc Daily Williams %R ChartAtossa Genetics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Atossa Genetics Inc.

Atossa Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atossa Genetics Inc. The current atr is 0.0981494.

Atossa Genetics Inc Daily Average True Range (ATR) ChartAtossa Genetics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atossa Genetics Inc. The current obv is 12,128,339.

Atossa Genetics Inc Daily On-Balance Volume (OBV) ChartAtossa Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Atossa Genetics Inc. The current mfi is 74.36.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Atossa Genetics Inc Daily Money Flow Index (MFI) ChartAtossa Genetics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Atossa Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Atossa Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Atossa Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.235
Ma 20Greater thanMa 501.097
Ma 50Greater thanMa 1000.974
Ma 100Greater thanMa 2000.857
OpenGreater thanClose1.290
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Atossa Genetics Inc with someone you think should read this too:
  • Are you bullish or bearish on Atossa Genetics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Atossa Genetics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Atossa Genetics Inc

I send you an email if I find something interesting about Atossa Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Atossa Genetics Inc.

Receive notifications about Atossa Genetics Inc in your mailbox!